The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses
The Primary Care Companion For CNS Disorders · 2023
DOI: 10.4088/pcc.22nr03433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Primary Care Companion For CNS Disorders, 2023. Verfasst von Grace E Hartmann und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas School of Medicine, Kansas City, Kansas. Hauptthemen laut MEDLINE: Drug Overdose, Opiate Overdose, Opioid-Related Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Kansas School of Medicine, Kansas City, Kansas.
- Department of Addiction Psychiatry, University of Kansas Health System, Kansas City, Kansas.
- Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, Kansas.
- Corresponding Author: Roopa Sethi, MD, Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Blvd, Mail Stop 4015, Kansas City, KS 66160 (rsethi@kumc.edu).
Zitieren
APA
Hartmann, G. E., & Sethi, R. (2023). The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.22nr03433
Vancouver
Hartmann GE, Sethi R. The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses. The Primary Care Companion For CNS Disorders. 2023. doi:10.4088/pcc.22nr03433
BibTeX
@article{Hartmann2023,
author = {Hartmann, Grace E and Sethi, Roopa},
title = {The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses},
journal = {The Primary Care Companion For CNS Disorders},
year = {2023},
doi = {10.4088/pcc.22nr03433}
}
EUVIMED